Israel’s MediWound Ltd., a biotech firm that makes burn and wound treatments, said that it has received a new contract for up to $43 million from the US Biomedical Advanced Research and Development Authority (BARDA) to adapt its lead product, a gel based on pineapple enzymes for the treatment ofContinue Reading